Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
05/01/201908:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/12/201809:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/12/201808:01PR Newswire (US)Regeneron Announces Presentation at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/12/201808:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
18/12/201808:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/201808:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
02/12/201804:00PR Newswire (US)Regeneron Presents Positive Data at ASH for REGN1979 CD20xCD3 Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgki...NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/11/201809:00PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/11/201808:34Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/11/201800:29Dow Jones NewsZiopharm in Supply Agreement with Regeneron to Study Glioblastoma TreatmentNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/11/201800:15PR Newswire (US)ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was associated with fewer deaths from ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/11/201800:14PR Newswire (US)ODYSSEY OUTCOMES Investigators Highlight at AHA that Praluent® (alirocumab) Injection Was Associated with Fewer Deaths from ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/11/201809:01PR Newswire (US)New England Journal of Medicine Publishes Positive Detailed Results From Praluent® (alirocumab) Injection Cardiovascular Out...NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/11/201809:00PR Newswire (US)New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) Injection cardiovascular out...NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/11/201803:14Dow Jones NewsRegeneron, Sanofi Get FDA Priority Review for Dupixent in AdolescentsNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/11/201800:00PR Newswire (US)FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-se...NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201823:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201823:42Dow Jones NewsRegeneron Posts Higher Profits Led By Treatment AdvancesNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201823:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201822:30PR Newswire (US)Regeneron Reports Third Quarter 2018 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201816:59PR Newswire (US)FDA Grants Priority Review for Dupixent® (dupilumab) as Potential Treatment for Adolescents with Uncontrolled Moderate-to-Se...NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/10/201822:00PR Newswire (US)Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science MagazineNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN

Your Recent History

Delayed Upgrade Clock